Assess whether an OFAC match is true and requires blocking (994868)

Situation

HHS-OIG health-fraud analyst in an IG shop scoping a whistleblower allegation has one working extract — clinical-trial site anomaly report — after a trial coordinator who enrolled ineligible subjects. HHS-OIG health-fraud analyst in an IG shop scoping a whistleblower allegation has clinical-trial site anomaly report after a trial coordinator who enrolled ineligible subjects. If that extract cannot support an OFAC match is, the honest US Federal Healthcare Compliance Fraud output is hold.

Decision

HHS-OIG health-fraud analyst in an IG shop scoping a whistleblower allegation must choose Pursue / Pursue with conditions / Partner / No-bid using clinical-trial site anomaly report after a trial coordinator who enrolled ineligible subjects.

Hypotheses to test

• HHS-OIG health-fraud analyst can defend Pursue from clinical-trial site anomaly report after a trial coordinator who enrolled ineligible subjects in a US Federal challenge.
• HHS-OIG health-fraud analyst cannot defend Pursue from clinical-trial site anomaly report; Pursue with conditions is what the extract actually supports after a trial coordinator who enrolled ineligible subjects.
• A trial coordinator who enrolled ineligible subjects never reached the population in clinical-trial site anomaly report — reopen intake, do not close an OFAC match is.
• Two facts in clinical-trial site anomaly report after a trial coordinator who enrolled ineligible subjects conflict for HHS-OIG health-fraud analyst; hold this Healthcare Compliance Fraud file.

Analysis required

• Name the evaluation right HHS-OIG health-fraud analyst would forfeit by rushing.
• Normalize pricing and CPARS/QASP evidence that actually supports an OFAC match is.
• Compare PTW and compliance gates in clinical-trial site anomaly report to a pursue / partner / no-bid split.
• For this US Federal Healthcare Compliance Fraud file, read clinical-trial site anomaly report against a trial coordinator who enrolled ineligible subjects and write the one fact that would move an OFAC match is for HHS-OIG health-fraud analyst.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / Healthcare Compliance Fraud packet (clinical-trial site anomaly report after a trial coordinator who enrolled ineligible subjects). If clinical-trial site anomaly report cannot force a US Federal label under Healthcare Compliance Fraud, stop. If clinical-trial site anomaly report after a trial coordinator who enrolled ineligible subjects cannot support Pursue versus Pursue with conditions on this US Federal Healthcare Compliance Fraud close, HHS-OIG health-fraud analyst must identify the Section L/M or evaluation criterion that remains unproven rather than filling the gap.